References
- 1. Bisceglia G, Mastrodonato N, Tardio B, et al. Intermediate neoadjuvant adiotherapy for T3 low/middle rectal cancer: Postoperative outcomes of a non-controlled clinical trial. 4294367 Oncotarget. 2014;5(22):11143-11153.PMCID:4294367
- 2. Mulsow J, Winter DC. Sphincter preservation for distal rectal cancer - a goal worth achieving at all costs? World J Gastroenterol 2011;17(7):855-861.doi:10.3748/wjg.v17.i7.855
- 3. Spanos C P. Intersphincteric resection for low rectal cancer: An overview. Int J Surg Oncol. 2012;2012:241512.doi:10.1155/2012/241512
- 4. Musio D, De Felice F, Bulzonetti N, et al. Neoadjuvant-intensified treatment for rectal cancer: Time to change? World J Gastroenterol. 2013;19(20):3052-3061.doi:10.3748/wjg.v19.i20.3052
- 5. Schiessel R, Novi G, Holzer B, et al. Technique and long-term results of intersphincteric resection for low rectal cancer. Dis Colon Rectum 2005;48:1858-1867.doi:10.1007/s10350-005-0134-5
- 6. Heald R J. The ’holy plane’ of rectal surgery. J R Soc Med 1988;81(9):503-508.doi:10.1177/014107688808100904
- 7. Cipe G, Muslumanoglu M, Yardimci E, Memmi N, Aysan E. Intersphincteric resection and coloanal anastomosis in treatment of distal rectal cancer. Int J Surg Oncol. 2012;2012:581258.doi:10.1155/2012/581258
- 8. Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum. 1993;36(1):77-97
- 9. Deo S V S, Kapali A S, Gupta M, Shukla N K. A review of controversies in the management of colorectal cancers. Indian J Surg. 2012;74(3):221-227.doi:10.1007/s12262-012-0586-5
- 10. Rullier E, Goffre B, Bonnel C, Zerbib F, Caudry M, Saric J. Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum. Ann Surg. 2001;234(5):633-640. PMCID:1422087